BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 16412791)

  • 1. Diagnosis and treatment of chronic graft-versus-host disease.
    Gilman AL; Serody J
    Semin Hematol; 2006 Jan; 43(1):70-80. PubMed ID: 16412791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic graft-versus-host disease: clinical manifestation and therapy.
    Ratanatharathorn V; Ayash L; Lazarus HM; Fu J; Uberti JP
    Bone Marrow Transplant; 2001 Jul; 28(2):121-9. PubMed ID: 11509929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Graft-versus-host disease: a complex long-term side effect of hematopoietic stem cell transplant.
    Barton-Burke M; Dwinell DM; Kafkas L; Lavalley C; Sands H; Proctor C; Johnson E
    Oncology (Williston Park); 2008 Oct; 22(11 Suppl Nurse Ed):31-45. PubMed ID: 19856578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Life-threatening graft-vs-host disease.
    Vargas-Díez E; García-Díez A; Marín A; Fernández-Herrera J
    Clin Dermatol; 2005; 23(3):285-300. PubMed ID: 15896544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal management of chronic graft-versus-host disease in children.
    Jacobsohn DA
    Br J Haematol; 2010 Aug; 150(3):278-92. PubMed ID: 20553274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical update on graft-versus-host disease in children.
    Goddard DS; Horn BN; McCalmont TH; Cordoro KM
    Semin Cutan Med Surg; 2010 Jun; 29(2):92-105. PubMed ID: 20579598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colonic graft-versus-host disease.
    Ross WA; Couriel D
    Curr Opin Gastroenterol; 2005 Jan; 21(1):64-9. PubMed ID: 15687887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic graft-versus-host disease.
    Horwitz ME; Sullivan KM
    Blood Rev; 2006 Jan; 20(1):15-27. PubMed ID: 16426941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The changing face of graft-versus-host disease.
    Schaffer JV
    Semin Cutan Med Surg; 2006 Dec; 25(4):190-200. PubMed ID: 17174839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Graft-versus-host disease: review and nursing implications.
    Mattson MR
    Clin J Oncol Nurs; 2007 Jun; 11(3):325-8. PubMed ID: 17623617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autologous graft-versus-host disease: harnessing anti-tumor immunity through impaired self-tolerance.
    Kline J; Subbiah S; Lazarus HM; van Besien K
    Bone Marrow Transplant; 2008 Mar; 41(6):505-13. PubMed ID: 18026144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expanded donor natural killer cell and IL-2, IL-15 treatment efficacy in allogeneic hematopoietic stem cell transplantation.
    Chen G; Wu D; Wang Y; Cen J; Feng Y; Sun A; Tang X; Chang H; Zhu Z
    Eur J Haematol; 2008 Sep; 81(3):226-35. PubMed ID: 18573173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An overview of chronic oral graft-vs-host disease following pediatric hematopoietic stem cell transplantation.
    da Fonseca MA; Hong C
    Pediatr Dent; 2008; 30(2):98-104. PubMed ID: 18481573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects and prognostic factors of HLA-matched sibling donor allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia].
    Tong XZ; Li J; Tan EX; Zhang GC; Wu XY; Peng AH; Zheng D; Zou WY; Hong WD; Luo SK
    Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):545-8. PubMed ID: 17147125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic graft-versus-host disease: is there an alternative to the conventional treatment?
    Gaziev D; Galimberti M; Lucarelli G; Polchi P
    Bone Marrow Transplant; 2000 Apr; 25(7):689-96. PubMed ID: 10745252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced intensity conditioning for allogeneic hematopoietic stem-cell transplant determines the kinetics of acute graft-versus-host disease.
    Turner BE; Kambouris ME; Sinfield L; Lange J; Burns AM; Lourie R; Atkinson K; Hart DN; Munster DJ; Rice AM
    Transplantation; 2008 Oct; 86(7):968-76. PubMed ID: 18852664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel strategies for the treatment and diagnosis of graft-versus-host-disease.
    Ferrara JL
    Best Pract Res Clin Haematol; 2007 Mar; 20(1):91-7. PubMed ID: 17336259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Influence of graft-versus-host disease on long-term survival of 26 patients with hematologic malignancies after transplantation].
    Lin Q; Dong M; Wang QM; Wen JY; Wu XY
    Ai Zheng; 2006 Oct; 25(10):1261-5. PubMed ID: 17059772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylaxis and treatment of acute graft-versus-host disease.
    Chao NJ; Chen BJ
    Semin Hematol; 2006 Jan; 43(1):32-41. PubMed ID: 16412787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.